JP Morgan Chase’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
SCM
AIM
NAMI
TFCM
YLHM
JP Morgan Chase's CGEN Position: Q1 2026 in Review
JP Morgan Chase reduced its Compugen (CGEN) stake by 29% in Q1 2026, selling an estimated $1.66K and leaving 2,070 shares worth $4.12K. The position accounts for ﹤0.01% of the portfolio, ranked #6914.
JP Morgan Chase first reported a position in CGEN in Q2 2017 and has held it in 25 quarters since. The position peaked at $2.22M in Q1 2021. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.
- JP Morgan Chase held 2,070 shares of Compugen worth $4.12K as of Q1 2026.
- JP Morgan Chase sold 856 Compugen shares in Q1 2026, an estimated $1.66K.
- Compugen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6914 holding.
- JP Morgan Chase first reported a position in Compugen in Q2 2017 and has held it in 25 quarters since.
- JP Morgan Chase's Compugen position peaked at $2.22M in Q1 2021.
- 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.